Elotuzumab in Patients With Multiple Myeloma Before and After Peripheral Stem Cell Autologous Graft
Clinical trial NCT03393273 · WITHDRAWN
Trial details
- NCT number
- NCT03393273
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-20
- Primary completion
- 2019-01-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.